Cancer Communications
indexed by SCI
BMC
Home > About the journal

Started in 1982


ISSN: 2523-3548


Supervisor

Ministry of Education, P. R. China

Sponsor

Sun Yat-sen University Cancer Center


Cancer Communications (former title: Chinese Journal of Cancer) publishes original research, reviews, extra views, perspectives, supplements, and spotlights in all areas of cancer research. The primary criteria for publication in CC are originality, outstanding scientific merit, and general interest. The Editorial Board is composed of members from around the world, who will strive to maintain the highest standards for excellence in order to generate a valuable resource for an international readership.


Editorial Board


Honorary Editor-in-Chief

Yi-Xin Zeng
Chinese Academy of Science member, China

 

Editor-in-Chief

Rui-Hua Xu
Sun Yat-sen University Cancer Center, China

Deputy Editor-in-Chief

Peng Huang
Sun Yat-sen University Cancer Center, China

Associate Editors

Chao-Nan Qian
Sun Yat-sen University Cancer Center, China

Wei Zhang
Wake Forest Baptist Comprehensive Cancer Center, USA



Editorial Board

Anil Sood
M.D. Anderson Cancer Center, USA

Anthony T.C. Chan
The Chinese University of Hong Kong, China

Bin S Teh
Methodist Hospital, USA

Boris Pasche
Comprehensive Cancer Center of Wake Forest University, USA

Carl-Henrik Heldin
Uppsala University, Sweden

Carlos L. Arteaga
Vanderbilt-Ingram Cancer Center, Vanderbilt University, USA

Cunyu Wang
University of California Los Angeles School of Dentistry, USA

Delia Mezzanzanica
Fondazione IRCCS Istituto Nazionale dei Tumori, Italy

Dennis Lo
The Chinese University of Hong Kong, China

Dong-Xin Lin
Chinese Academy of Medical Sciences, China

Er-Wei Song
Sun Yat-sen Memorial Hospital, China

Fang-Jian Zhou
Sun Yat-sen University Cancer Center, China

Gerry Melino
University of Rome, Italy

Gregory N. Fuller
University of Texas MD Anderson Cancer Center, USA

Guido Kroemer
INSERM, France

Ilya Shmulevich
Institute for Systems Biology, USA

Ingemar Ernberg
Karolinska Institute, Sweden

Jeff MacKeigan
Van Andel Research Institute, USA

Jian Zhang
Guangxi Medical University, China

Jian-Hua Fu
Sun Yat-sen University Cancer Center, China

Jie He
Chinese Academy of Medical Sciences, China

Jinsong Liu
MD Anderson Cancer Center, USA

Joseph Wee
National Cancer Center, Singapore

Joe Y. Chang
M.D. Anderson Cancer Center, USA

Jun Yan
University of Louisville, USA

Ju-Seog Lee
M.D. Anderson Cancer Center, USA

Jun Ma
Sun Yat-sen University Cancer Center, China

Keng Shen
Peking Union Medical College, China

Ke-Xin Chen
Tianjin Medical University, China

Kwok Wai Lo
The Chinese University of Hong Kong, China

Laurence J.N. Cooper
University of Texas MD Anderson Cancer Center, USA

Lawrence S. Young
University of Birmingham, UK

Lei Zheng
The John Hopkins University School of Medicine, USA

Li Yan
GlaxoSmithKline PLC., UK

Li Zhang
Sun Yat-sen University Cancer Center, China

Li-Wu Fu
Sun Yat-sen University Cancer Center, China

Maria Masucci
Karolinska Institute, Sweden

Mikhail V. Blagosklonny
Roswell Park Cancer Institute, USA

Ming Zhou
Glickman Urological Institute, USA

Mu-Sheng Zeng
Sun Yat-sen University Cancer Center, China

Neal Rosen
Memorial Sloan-Kettering Cancer Center, USA

Olli Yli-Harja
Tampere University of Technology, Finland

Paul J. Chiao
M.D. Anderson Cancer Center, USA

Qian Tao
The Chinese University of Hong Kong, China

Qiang Liu
Sun Yat-sen University Cancer Center, China

Rajiv Khanna
QIMR Berghofer Medical Research Institute, Australia

René-O. Mirimanoff
University of Lausanne Medical Center,Switzerland

Richard Knight
Medical Research Council, UK

Sharlene Gill
BC Cancer Agency, Vancouver, Canada

Sheng-Ping Li
Sun Yat-sen University Cancer Center, China

Shiyuan Cheng
University of Pittsburgh Cancer Institute, USA

Sujuan Ba
National Foundation for Cancer Research, USA

Sven Brandau
University Hospital Essen, Germany

Takeo Nakanishi
Kanazawa University, Japan

Theo Knijnenburg
Institute for Systems Biology, Japan

Wan-Qing Chen
Peking Union Medical College, China

Webster K. Cavenee
University of California at San Diego, USA

Wei-Ping Zhou
University of Michigan, USA

Wen-Lin Huang
Sun Yat-sen University Cancer Center, China

Xiang-Xi (Mike) Xu
Sylvester Comprehensive Cancer Center, USA

Xiang Chen
St.Jude Children's Research Hospital, USA

Xiao-Feng Zhu
Sun Yat-sen University Cancer Center, China

Xiao-Ming Xie
Sun Yat-sen University Cancer Center, China

Ye-Xiong Li
Peking Union Medical College, China

Yi-Hai Cao
Karolinska Institute, Sweden

You-Lin Qiao
Peking Union Medical College, China

Yun-Fei Yuan
Sun Yat-sen University Cancer Center, China

Yuan Shan
Baylor Scott & White Medical Center, USA

Yunguang Tong
UCLA School of Medicine, USA

Zhe-Sheng Chen
St. John's University, USA

Zhi-Hua Liu
Peking Union Medical College, China

Zhi-Min Lu
Zhejiang University School of Medicine,China

Zhi-Wei Zhou
Sun Yat-sen University Cancer Center, China

 





Awards to the Cancer Communications (former title: Chinese Journal of Cancer)


CJC Wins the Title of 2019’ the Highest International Impact Academic Journal of China

CJC Wins the Title of 2018’ the Highest International Impact Academic Journal of China



CJC Wins the Title of 2017’ the Highest International Impact Academic Journal of China



CJC Wins the Title of 2016’ the Highest International Impact Academic Journal of China


CJC Wins the Title of 2015’ the Highest International Impact Academic Journal of China


CJC Wins the Title of 2014’ the Highest International Impact Academic Journal of China


CJC Wins the Title of 2013’ the Highest International Impact Academic Journal of China


Certificate of Outstanding S&T Journals of China 2014
 

Top 100 Outstanding Scientific Journals in China in the 2010 Chinese S&T Journal Citation Reports by the Institute of Scientific and Technical Information of China
 

Grade A+ journals (top 5% among 6400 journals in China), in the Chinese Scientific Journal Evaluation Report by the Research Center for Chinese Science Evaluation
 

CJC wins the title of the 2012' Excellent International Impact Academic Journal of China
 

Outstanding S&T Journal of China 2011
 

Top one among 29 oncology journals in China, in the 2010 Impact Factor Report of Chinese Technical Journals,Life Sciences and Technology Version
 




CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China